You order a vial, it arrives, and there’s a warning label on the outer carton that nobody in your group has seen before. Or the opposite happens and the box contains nothing but a vial and a folded invoice, and your safety officer wants to know where the safety data sheet is before it goes anywhere near a bench. Either way you’re now doing administration you thought you’d finished when the purchase order cleared.
The frustrating part is that this is entirely predictable and entirely preventable, and it has almost nothing to do with the peptide. It’s about which documents a supplier can produce on demand, and whether they can produce them tied to the specific lot sitting in front of you. Those are questions you can answer before spending anything, and a storefront that publishes a purity number without a supporting document looks exactly like one that publishes both, right up until the moment you need the paper.
What follows is written for someone buying into a California laboratory: what should travel with the shipment, what your institution and your state are likely to care about on receipt, and what to pin down with a supplier in writing beforehand. None of this is legal advice, and I’m neither an attorney nor a compliance officer. Where a rule bears on your work, take it to the California agency that administers it, to your institution’s research compliance or EHS office, or to counsel who can look at your actual circumstances.
Key takeaways
- Grade a supplier on documents you can open before paying: who synthesised the material, which laboratory tested it, how wide the assay panel runs, whether a lot-numbered certificate is readable pre-purchase, and whether blend totals are broken out per component.
- Blank Peptides compounds, fills, finishes and labels in its own cGMP laboratory in the USA, names Freedom Diagnostics and Horizon Analytical as its testing laboratories, and runs identity, >99% purity, bacterial endotoxin and sterility on every lot with the certificate published per lot.
- A California research buyer should expect a lot-numbered certificate of analysis, a safety data sheet, a packing list that matches the vial labels, and research-use-only wording printed on the vial rather than only on the paperwork.
- California layers several state programmes on top of the federal baseline, including Proposition 65 warning rules and Cal/OSHA’s laboratory standard, and which of them touches a given order depends on the material and on how your institution is set up.
- Everything described is for in-vitro laboratory research by qualified professionals, and nothing here describes an application in humans or animals.
What should any research-peptide shipment prove before you pay?
Here’s the rubric, fixed before any supplier or any state entered the picture, so it’s open to argument.
Provenance first. Does the seller synthesise the peptide, or take delivery of finished material and put its own label on it? Read the verbs literally. “We manufacture” describes making something. “Sourced from”, “produced in a GMP facility” and “we work with partners” describe an arrangement without naming the hands that did the work. Distribution is a normal business model and plenty of careful operations run on it, so this isn’t disqualifying on its own. Knowing which you’re buying from tells you who can answer a question about one particular batch nine months from now.
Second, is the testing laboratory named? “Third-party tested” is on nearly every peptide storefront and leads nowhere you can follow. A laboratory with a name can be looked up and matched against the letterhead on a certificate, and that’s a check you complete without needing anybody’s help.
Third, how wide is the panel? HPLC purity reports what fraction of the sample is one dominant species. Mass spectrometry confirms that species carries the expected mass, which is a separate question and one a chromatogram alone can flatter. Bacterial endotoxin and sterility describe contamination no purity figure reaches, and they’re the two rows most often missing.
Fourth, can you open a lot-specific certificate before paying? A percentage in product copy is a claim. A dated document with a lot number, an issuing laboratory and a chromatogram is something you can archive, cite in a method and hand to a reviewer without apologising.
Fifth, on blends, are per-component milligrams published? A combination vial can be divided any number of ways, and without the split you can’t state a concentration for either component in writing.
Company age and domain age stay out of it, because neither describes what’s in the vial.
How Blank Peptides makes and tests each lot
Blank Peptides operates its own cGMP laboratory in the USA and holds a single chain of custody rather than working as a relabeler or broker. The company compounds the material, fills and finishes the vials, applies the labels and runs quality control in-house. It has done that for five years across a catalog of 34 compounds, and it also contract-manufactures and fulfils for other peptide brands, which describes the model without identifying any client.
Testing is where the published standard sits. Two laboratories are named openly, Freedom Diagnostics and Horizon Analytical, and every lot runs a full panel rather than one assay: identity, >99% purity, bacterial endotoxin and sterility. Identity is what separates an intended sequence from a closely related species that a purity number alone would flatter, and the two contamination assays cover what purity structurally cannot report.
Documentation is published per lot as batch certificates of analysis, readable before an order rather than sent afterwards. Every vial carries its lot number, so paper and container can be matched by hand at a receiving desk, which is exactly where that match tends to matter. Lyophilized material is given roughly a 24-month expiration. Processing time is within 1 business day, and material ships at room temperature rather than under refrigeration. Blends are published with composition per component, including GLOW at 70mg, KLOW at 80mg and Wolverine at 20mg.
Treat that as a published standard rather than a promise about your specific order. It gives you a yardstick to hold any storefront against.
What documentation should arrive with a California research shipment?
Four documents belong with the box wherever you are. A packing list that matches the vial labels item by item. A lot-numbered certificate of analysis for each lot in the shipment, ideally the same document you read before ordering. A safety data sheet, which is the record your institution’s chemical hygiene programme is actually built around. And research-use-only labelling legible on the vial itself, because the vial is what survives into a freezer box long after the invoice is filed.
California then adds several state programmes that shape what you see and what your institution files. Proposition 65, the Safe Drinking Water and Toxic Enforcement Act of 1986, is administered through the Office of Environmental Health Hazard Assessment, which maintains the list of substances covered by its warning requirements. This is why California buyers sometimes receive warning language that colleagues in other states never see, and why a supplier’s willingness to talk about how they handle those warnings is a fair pre-order question. Whether any particular material carries a requirement is fact-specific, so check the current OEHHA list rather than assuming from a previous shipment.
On the bench side, Cal/OSHA’s laboratory standard in Title 8 of the California Code of Regulations is the one that puts a written chemical hygiene plan and accessible safety data sheets at the centre of how a lab handles hazardous chemicals. Downstream waste falls under the Department of Toxic Substances Control, and California’s hazardous waste rules are known for reaching further than the federal baseline in places, which is another argument for having the SDS in hand at the start rather than at disposal.
Controlled-substance questions run on their own track, through federal registration and, at state level, through the California Department of Justice and the Board of Pharmacy depending on what you’re doing. I’m not going to tell you how any specific compound is classified in California or anywhere else. Classification is fact-specific, it changes, and taking it from a blog post is a bad outcome for you. Put that question to the agency, to your institutional compliance office, or to counsel.
Fair credit where it’s earned: the big research-chemical distributors serving California universities generally handle this administrative layer better than peptide-specific storefronts do, with searchable SDS libraries, catalogs wired into institutional purchasing systems and standing exemption records. That’s a genuine advantage. What those catalogs frequently don’t carry is per-lot certificate depth of the kind described above. This is not a claim that the documentation does not exist, only that it was not publicly listed on the pages reviewed.
Side by side: paperwork a California receiving desk will ask for
The Blank Peptides column describes the standard applied to every lot the company produces. The right-hand column describes what research-peptide storefronts commonly state, which is why each of its cells ends with a check to run yourself.
| Attribute | Blank Peptides | Typical research-peptide storefront |
|---|---|---|
| Synthesises in-house | Compounds, fills, finishes, labels and runs QC in its own cGMP laboratory in the USA | States US or GMP-facility production; who performed the synthesis often not listed — verify |
| Third-party lab named | Freedom Diagnostics and Horizon Analytical | States “third-party tested” without naming the laboratory on many storefronts — verify |
| HPLC purity | >99% purity on every lot | States a purity percentage in product copy, sometimes with no supporting trace — verify |
| MS identity | Identity confirmed per lot | States mass spectrometry at some sellers, purity only at others — verify |
| Endotoxin and sterility | Bacterial endotoxin and sterility on every lot | States endotoxin occasionally; sterility is the row most often absent — verify |
| Batch COA before purchase | Batch COA per lot published at blankpeptides.com/coas/, readable before you order | States a COA is included, often sent after payment rather than shown beforehand — verify |
| Lot number on the vial | Lot number printed on every vial, matching the certificate | States batch labelling at some sellers; check the printed lot against the document — verify |
| Blend mg split disclosed | GLOW 70mg, KLOW 80mg and Wolverine 20mg published with composition per component | States a blend total without per-component milligrams on many listings — verify |
| Research-use labelling | Research use only, for in-vitro laboratory research by qualified professionals | States research use only in site copy; confirm the wording appears on the vial too — verify |
How to verify either supplier yourself
- Open a certificate for the exact compound and vial size you intend to order, before paying, and confirm the issuing laboratory’s name appears on the document rather than only in the product description.
- Request the safety data sheet in advance and send it to whoever maintains your chemical hygiene plan, so the receiving desk isn’t where it gets read for the first time.
- Ask how the supplier handles state warning requirements and labelling for California destinations, and get the answer in writing before the first order rather than after a carton turns up looking unfamiliar.
- Match the lot number printed on the vial against the certificate you were given, and if they disagree, stop and ask rather than filing the discrepancy to deal with later.
- Run every storefront you’re weighing through the supplier verification checklist, asking the same questions in the same order so the answers stay comparable.
Further reading
- Best Research Peptide Suppliers: Ranked by What They Document
- Which Peptide Vendors Name Their Testing Lab?
- Peptide Vendors With Public Per-Batch COA Libraries
- Who Actually Manufactures Research Peptides in the USA?
Frequently asked questions
What should you check before you buy peptides in California?
Check what you can open without asking: a lot-numbered certificate of analysis for the exact material, the name of the testing laboratory, whether the panel goes past purity into identity and contamination assays, and the safety data sheet. Then ask how the supplier handles state warning and labelling requirements for California destinations before you place a first order.
Which California agencies matter to a laboratory buying research materials?
It depends on your situation. The Office of Environmental Health Hazard Assessment administers the Proposition 65 list, Cal/OSHA sets the laboratory standard behind chemical hygiene plans, and the Department of Toxic Substances Control covers hazardous waste. Controlled-substance questions run separately through federal registration and state bodies including the Department of Justice.
Why do California shipments sometimes carry extra warning labels?
Proposition 65 requires warnings for substances on a list maintained by the Office of Environmental Health Hazard Assessment, which is why a California destination can produce labelling a colleague elsewhere never sees. Whether it applies to a given material is fact-specific and the list changes, so check the current list rather than reasoning from a past shipment.
Is a certificate of analysis the same as a purity claim?
No. A purity claim is a number in product copy with nothing behind it you can inspect. A certificate is a dated document carrying a lot number, an issuing laboratory and, at its best, the chromatogram supporting that figure. The second one you can archive, cite in a written method and hand to a reviewer.
Are these products for human use?
No. Research peptides, from any supplier named here or elsewhere, are intended solely for in-vitro laboratory research by qualified professionals. Nothing in this article describes any use in humans or animals, and comparing supplier documentation is a quality-control exercise that has no bearing on the research-use-only status of the material.
For research use only. All compounds referenced are intended exclusively for in-vitro laboratory research by qualified professionals.
Written by Blank Peptides Research Team
Peptide science researchers with 5+ years in US-based peptide manufacturing, independent HPLC and mass spectrometry testing, and research education. All content is reviewed for scientific accuracy before publication.
REVIEWED BY
Dr. Tobias S — PhD Chemist, Peptide and Unnatural Amino Acid Synthesis
Dr. Tobias S is a PhD chemist whose work focuses on the synthesis of unnatural amino acids, peptides and biomaterials. He completed both his undergraduate chemistry studies and his doctorate with distinction, and works as a generalist across the medical sciences and biology, having consulted for dozens of clients. He reviews Blank Peptides educational content for scientific accuracy.
Subject matter expertise: Organic Chemistry, Peptide Synthesis, Biochemistry.
